SE0302923L - Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav - Google Patents

Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav

Info

Publication number: SE0302923L
Authority: SE; Sweden
Prior art keywords: beta; boswellic acid; keto; acetyl; boswellin
Prior art date: 2002-03-13

Application number

SE0302923A

Other languages

English (en)

Other versions

SE0302923D0 (sv

Inventor

Allen L Seligson

Ronald C Terry

Daniel Alexander

Milos Sovak

Original Assignee

Biophysica Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-13

Filing date

2003-11-06

Publication date

2003-12-22

2003-11-06 Application filed by Biophysica Inc filed Critical Biophysica Inc

2003-11-06 Publication of SE0302923D0 publication Critical patent/SE0302923D0/sv

2003-12-22 Publication of SE0302923L publication Critical patent/SE0302923L/sv

Links

HMMGKOVEOFBCAU-GOBAHYPASA-N (3s,4r,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14bs)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid Chemical compound C1C[C@H](OC(C)=O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC(=O)[C@@H]3[C@]21C HMMGKOVEOFBCAU-GOBAHYPASA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
HMMGKOVEOFBCAU-BCDBGHSCSA-N 3-Acetyl-11-keto-beta-boswellic acid Chemical compound C1C[C@@H](OC(C)=O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC(=O)[C@@H]3[C@]21C HMMGKOVEOFBCAU-BCDBGHSCSA-N 0.000 title 1
HMMGKOVEOFBCAU-UHFFFAOYSA-N AKBA Natural products C1CC(OC(C)=O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CC(=O)C3C21C HMMGKOVEOFBCAU-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
230000004071 biological effect Effects 0.000 abstract 2
YIMHGPSYDOGBPI-YZCVQEKWSA-N 11-keto-β-boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC(=O)[C@@H]3[C@]21C YIMHGPSYDOGBPI-YZCVQEKWSA-N 0.000 abstract 1
NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 abstract 1
NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 abstract 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
YIMHGPSYDOGBPI-UHFFFAOYSA-N beta-KBA Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CC(=O)C3C21C YIMHGPSYDOGBPI-UHFFFAOYSA-N 0.000 abstract 1
239000000284 extract Substances 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1
235000017807 phytochemicals Nutrition 0.000 abstract 1
239000000419 plant extract Substances 0.000 abstract 1
229930000223 plant secondary metabolite Natural products 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
239000000741 silica gel Substances 0.000 abstract 1
229910002027 silica gel Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Natural Medicines & Medicinal Plants (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

SE0302923A 2002-03-13 2003-11-06 Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav SE0302923L (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36429902P	2002-03-13	2002-03-13
PCT/US2003/007733 WO2003077860A2 (en)	2002-03-13	2003-03-12	BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES

Publications (2)

Publication Number	Publication Date
SE0302923D0 SE0302923D0 (sv)	2003-11-06
SE0302923L true SE0302923L (sv)	2003-12-22

Family

ID=28041898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0302923A SE0302923L (sv)	2002-03-13	2003-11-06	Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav

Country Status (4)

Country	Link
US (1)	US20030199581A1 (sv)
AU (1)	AU2003220240A1 (sv)
SE (1)	SE0302923L (sv)
WO (1)	WO2003077860A2 (sv)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE513553T1 (de) *	2002-03-05	2011-07-15	Laila Impex	Verfahren zur herstellung einer fraktion, die bis zu 100 mit 3-o-acetyl-11-keto-beta- boswellinsäure aus einem extrakt, der ein gemisch aus boswellinsäuren enthält, angereichert ist
US7977049B2 (en)	2002-08-09	2011-07-12	President And Fellows Of Harvard College	Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US7300351B2 (en) *	2003-06-30	2007-11-27	Wms Gaming Inc.	Gaming machine having a player time-selectable bonus award scheme
JP2007530417A (ja)	2003-07-01	2007-11-01	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	細胞及び生物の寿命及びストレス応答を操作するための組成物
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
US20050171027A1 (en)	2003-12-29	2005-08-04	President And Fellows Of Harvard College	Compositions for treating or preventing obesity and insulin resistance disorders
WO2006006178A1 (en) *	2004-07-08	2006-01-19	Ganga Raju Gokaraju	Novel structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
ITRM20040439A1 (it) *	2004-09-16	2004-12-16	Ca Di Group S R L	Prodotto con azione antinfiammatoria selettiva e azione contro la fibrogenesi tissutale.
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
EP1850840A2 (en) *	2005-01-13	2007-11-07	Sirtris Pharmaceuticals, Inc.	Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
JP5134530B2 (ja) *	2005-03-07	2013-01-30	ライラニュートラシューティカルズ	ボスウェル酸及び選択的に濃縮したボスウェル酸の新規な塩、ならびにそのための方法
WO2006138418A2 (en)	2005-06-14	2006-12-28	President And Fellows Of Harvard College	Improvement of cognitive performance with sirtuin activators
MX338626B (es)	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP1968630B1 (en)	2005-12-29	2018-01-24	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions
WO2008036932A2 (en) *	2006-09-21	2008-03-27	Herbalscience Singapore Pte. Ltd.	Compositions and methods comprising boswellia species
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
JP5200223B2 (ja)	2006-12-15	2013-06-05	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
CN101686725A (zh)	2007-04-03	2010-03-31	刚迦·拉贾·高卡拉贾	消炎和抗氧化协同作用的膳食补充组合物
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR20100113582A (ko)	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
KR101682512B1 (ko) *	2008-09-15	2016-12-05	라일라 뉴트라슈티칼스	보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
AU2008240335C1 (en) *	2008-10-31	2014-10-16	Software AG-Stiftung	Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
PH12012501787A1 (en)	2010-03-15	2012-12-10	Laila Nutraceuticals	Boswellia oil, its fractions and compositions for enhancing brain function
EP3338773A1 (en) *	2010-09-22	2018-06-27	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of langerhans
KR101723272B1 (ko)	2011-06-21	2017-04-18	비브이더블유 홀딩 에이쥐	보스웰릭산을 포함하는 메디컬 디바이스
CN103193852A (zh) *	2012-01-06	2013-07-10	苏州博创园生物医药科技有限公司	用于治疗结肠癌的化合物及其制备方法
ITPD20120343A1 (it) *	2012-11-13	2014-05-14	Matteo Bevilacqua	Composto in particolare per la cura della depressione e dell'ansia
CN103897010B (zh) *	2012-12-25	2017-07-11	苏州博创园生物医药科技有限公司	一种用于治疗银屑病的组合物及制备方法
US9505808B2 (en)	2013-10-02	2016-11-29	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 protein variant and virus like particles composed thereof
CN104672293B (zh)	2013-11-30	2017-01-18	苏州博创园生物医药科技有限公司	一种五环三萜结构修饰化合物及其制备方法和应用
WO2015166462A1 (en) *	2014-04-30	2015-11-05	Al-Harrisi Ahmed	Method of purifying 3-o-acetyl-11-keto-beta-boswellic acid (akba)
JP7079551B2 (ja)	2016-10-04	2022-06-02	ニュートラマックスラボラトリーズ，インコーポレイテッド	ヒドロキシチロソールおよびボスウェリン酸を有する組成物
US10342802B2 (en) *	2016-10-04	2019-07-09	Nutramax Laboratories, Inc.	Compositions comprising hydroxytyrosol and boswellic acid
IT201900004633A1 (it) *	2019-03-28	2020-09-28	Symbiosis Snc Di Veronese Eros E Ghisellini Denis	Preparato in soluzione idroalcolica e suo processo di produzione
CN116102611A (zh) *	2021-11-10	2023-05-12	中国医学科学院药物研究所	11-羰基-β-乙酰乳香酸治疗肺损伤及肺纤维化的应用
US20250170196A1 (en) *	2022-02-07	2025-05-29	Livful Inc.	Anti-inflammatory, immunomodulatory and analgesic agents from tree exudates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2711060B1 (fr) *	1993-10-13	1995-11-17	Oreal	Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
DE4445728A1 (de) *	1994-12-21	1996-06-27	Simmet Th Prof Dr	Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5629351A (en) *	1995-04-13	1997-05-13	Council Of Scientific & Industrial Research	Boswellic acid compositions and preparation thereof
US6224871B1 (en) *	1998-03-11	2001-05-01	Reliv International, Inc.	Dietary supplement for nutritionally promoting healthy joint function
AU4972599A (en) *	1998-07-07	2000-01-24	Transdermal Technologies, Inc.	Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
US6492429B1 (en) *	2000-07-10	2002-12-10	N.V. Nutricia	Composition for the treatment of osteoarthritis

2003
- 2003-03-12 WO PCT/US2003/007733 patent/WO2003077860A2/en not_active Ceased
- 2003-03-12 US US10/387,024 patent/US20030199581A1/en not_active Abandoned
- 2003-03-12 AU AU2003220240A patent/AU2003220240A1/en not_active Abandoned
- 2003-11-06 SE SE0302923A patent/SE0302923L/sv not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003077860A2 (en)	2003-09-25
US20030199581A1 (en)	2003-10-23
AU2003220240A8 (en)	2003-09-29
SE0302923D0 (sv)	2003-11-06
AU2003220240A1 (en)	2003-09-29
WO2003077860A3 (en)	2004-04-08

Legal Events

Date	Code	Title	Description
2005-11-08	NAV	Patent application has lapsed

Publication	Publication Date	Title
SE0302923L (sv)	2003-12-22	Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav
DE60116625D1 (de)	2006-04-06	Therapeutische kombinationen von fettsäuren
ATE356113T1 (de)	2007-03-15	Probucolbernsteinsäureester zur hemmung der expression von vcam-1
DE60313597D1 (de)	2007-06-14	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0307564A (pt)	2004-12-21	Derivados de nicotinamida úteis como inibidores de pde4
DE69720787D1 (de)	2003-05-15	Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
IL101761A0 (en)	1992-12-30	Fatty acid based compositions for the control of established plant infections
EA200400482A1 (ru)	2004-12-30	Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE60027376D1 (de)	2006-05-24	Zusammensetzungen, enthaltend Pinolensäure sowie deren Verwendung zur Gesundheitserhaltung
BR0010194A (pt)	2002-02-13	Composição farmacêutica sob a forma unitária, contendo o ácido acetilsalicìlico e hidrogenossulfato de clopidogrel
BR9913589A (pt)	2001-06-05	Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
CN103463953A (zh)	2013-12-25	一种甲醛去除剂
DE602004017871D1 (de)	2009-01-02	Zubereitungen zur behandlung von arthritischen erscheinungen
SE9701161D0 (sv)	1997-03-27	New use I
FI862609A0 (fi)	1986-06-18	Akne motverkande produkt.
TR200002078T2 (tr)	2000-11-21	Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
EE200200337A (et)	2003-10-15	Uued ühendid ning nende kasutamine
CN103493850A (zh)	2014-01-08	一种空气净化机专用空气抗菌剂
DE69927260D1 (de)	2005-10-20	Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DK1651194T3 (da)	2010-07-26	Stabile farmaceutiske sammensætninger med kontrolleret frigivelse, hvilke indeholder fenofibrat og pravastatin
ATE370742T1 (de)	2007-09-15	Petasinfreie polare petasitesextraktfraktionen und deren verwendung zur schmerzbehandlung
DK1212072T3 (da)	2004-06-21	Farmaceutisk præparat omfattende eukalyptus- og orangeolie
BR0107763A (pt)	2002-11-12	âteres de dicarboxilato de cálcio, métodos para a sua fabricação, e tratamento de doenças vasculares e diabetes com os mesmos
FR2835429B1 (fr)	2006-02-10	Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique
RU97107625A (ru)	1999-05-20	Средство для комплексного лечения ожоговых и посттравматических ран